CD74 and renal cell carcinoma: A follow-up study investigated CD74 autoantibody levels in the plasma of Japanese patients with renal cell carcinoma receiving ICB combination or monotherapy; in this work, CD74 autoantibody levels did not represent a predictive biomarker of pneumonitis irAE or higher-grade irAEs [94].